Menu
← Oncology Approval Tracker
FDA DECISION ·
Pedmark
sodium thiosulfate · Fennec Pharmaceuticals
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Reduction of cisplatin-related ototoxicity in pediatric patients age one month or older with localized, nonmetastatic solid tumors.
LAMPGEN ANALYSIS
Why it matters
This action addresses a potentially permanent treatment complication in a defined pediatric group.
What research teams should watch
Coordinate dose timing relative to cisplatin and establish baseline and serial audiology assessments.
PRIMARY RECORDS